https://www.amazon.com/Catalyst-Quest-Unlock-Deepest-Secrets/dp/1324050683
Posts Tagged ‘init0mg’
The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets: Cech, Thomas R.: 9781324050681: Amazon.com: Books
January 3, 2025Amazon.com: Why We Die: The New Science of Aging and the Quest for Immortality eBook : Ramakrishnan, Venki: Kindle Store
December 31, 2024jbgdiv0mg
December 31, 2024yuck….
Medreceiptforfk
December 31, 2024receipt for reimbursement
updateautopay947to400
December 31, 2024autopay things
Rough Diamonds on Netflix
December 22, 2024Co-Intelligence: Living and Working with AI: Mollick, Ethan: 9780593716717: Amazon.com: Books
December 22, 2024Amazon.com: Jimmy Breslin: The Man Who Told the Truth eBook : Esposito, Richard: Kindle Store
December 15, 2024The battle over the trillion-dollar weight-loss bonanza
October 4, 2024https://www.economist.com/business/2024/03/04/the-battle-over-the-trillion-dollar-weight-loss-bonanza glp-1 agonists
QT:{{”
The drugs’ biggest impact so far, though, has been on their makers. Sales of Wegovy, developed by a Danish firm called Novo Nordisk, swelled from $876m in 2022 to $4.5bn in 2023. The company expects double that this year. Zepbound, introduced in America in November by Eli Lilly, an American pharma giant, is expected to generate $2.9bn in sales in its first full year. Bloomberg, a data provider, predicts that by 2030 yearly sales of weight-loss medications will reach a staggering $80bn, putting them among the biggest classes of drugs in history. Eli Lilly and Novo Nordisk are expected to corner more than 90% of the market (see chart 2).
“}}
